mRNA-based and adenoviral vector-based COVID-19 vaccines elicit diverse humoral immunity

By | September 22, 2021
Scientists from the USA have recently compared the dynamics of humoral and cellular immune responses induced by mRNA-based and adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccines. The findings reveal a difference in humoral immune responses. The study is currently available on the medRxiv* preprint server.